We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+15.63%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+258.3%
AUM
$925M
AUM Growth
+$121M
Cap. Flow
-$1.06M
Cap. Flow %
-0.11%
Top 10 Hldgs %
22.31%
Holding
255
New
7
Increased
77
Reduced
98
Closed
5

Top Buys

Rank Stock Value
1
APD icon
Air Products & Chemicals
APD
+$6.4M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$2.73M
3
CVS icon
CVS Health
CVS
+$2.43M
4
MSFT icon
Microsoft
MSFT
+$2.14M
5
V icon
Visa
V
+$1.6M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$7.75M
2
CELG
Celgene Corp
CELG
+$5.4M
3
AL
Air Lease Corp
AL
+$2.84M
4
AMT icon
American Tower
AMT
+$1.93M
5
KMI icon
Kinder Morgan
KMI
+$1.36M

Sector Composition

Rank Sector Weight
1 Healthcare 16.89%
2 Technology 16.36%
3 Industrials 11.15%
4 Consumer Staples 8.91%
5 Financials 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WELL icon
101
Welltower
WELL
$171B
$2.11M 0.23%
27,240
+249
+0.9% +$18.7K
AMGN icon
102
Amgen
AMGN
$222B
$2.02M 0.22%
10,641
-20
-0.2% -$3.82K
AXP icon
103
American Express
AXP
$230B
$2.01M 0.22%
18,368
-923
-5% -$97K
AL
104
DELISTED
Air Lease Corp
AL
$2M 0.22%
58,307
-78,627
-57% -$2.84M
VXF icon
105
Vanguard Extended Market ETF
VXF
$31.7B
$1.98M 0.21%
17,109
+28
+0.2% +$3.14K
BMY icon
106
Bristol-Myers Squibb
BMY
$132B
$1.96M 0.21%
41,113
-279
-0.7% -$13.9K
T icon
107
AT&T
T
$163B
$1.92M 0.21%
81,084
-388
-0.5% -$8.93K
DEO icon
108
Diageo
DEO
$53.6B
$1.86M 0.2%
11,399
+379
+3% +$57.8K
ITW icon
109
Illinois Tool Works
ITW
$84.5B
$1.85M 0.2%
12,917
-200
-2% -$27.7K
VEA icon
110
Vanguard FTSE Developed Markets ETF
VEA
$236B
$1.81M 0.2%
44,216
-465
-1% -$18.6K
XRAY icon
111
Dentsply Sirona
XRAY
$2.43B
$1.78M 0.19%
35,891
-2,837
-7% -$125K
HOLX
112
DELISTED
Hologic
HOLX
$1.74M 0.19%
35,970
-10,870
-23% -$490K
SLB icon
113
SLB Ltd
SLB
$75B
$1.72M 0.19%
39,571
+3,202
+9% +$138K
ADI icon
114
Analog Devices
ADI
$190B
$1.72M 0.19%
16,344
+1,126
+7% +$113K
NTRS icon
115
Northern Trust
NTRS
$33.9B
$1.61M 0.17%
17,851
+150
+0.8% +$13.5K
BSX icon
116
Boston Scientific
BSX
$71.5B
$1.58M 0.17%
41,305
+1,675
+4% +$64K
HUBB icon
117
Hubbell
HUBB
$27.2B
$1.56M 0.17%
13,250
– –
WM icon
118
Waste Management
WM
$91B
$1.56M 0.17%
15,000
+1,300
+9% +$127K
ILMN icon
119
Illumina
ILMN
$28.4B
$1.49M 0.16%
4,940
+191
+4% +$55.7K
TT icon
120
Trane Technologies
TT
$106B
$1.47M 0.16%
13,580
– –
ADBE icon
121
Adobe
ADBE
$105B
$1.45M 0.16%
5,443
+3,061
+129% +$772K
NOW icon
122
ServiceNow
NOW
$129B
$1.44M 0.16%
29,265
+5,200
+22% +$229K
KMI icon
123
Kinder Morgan
KMI
$68.7B
$1.44M 0.16%
71,851
-73,095
-50% -$1.36M
DGS icon
124
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.77B
$1.42M 0.15%
30,118
+433
+1% +$19.8K
KMB icon
125
Kimberly-Clark
KMB
$36.5B
$1.41M 0.15%
11,352
-58
-0.5% -$6.74K
3 4
5
6 7

Similar funds

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
SGM
Seven Grand Managers Bronxville, New York $1.5B AUM 57.16% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CPA
Capital Performance Advisors Walnut Creek, California $1.5B AUM 21.4% 1-Year Est. Return
MCM
Maple Capital Management Montpelier, Vermont $1.49B AUM 23.46% 1-Year Est. Return

Boston Family Office's Q1 2019 Portfolio in Review

As of Q1 2019, Boston Family Office held 255 positions worth $925M, up 15% from $804M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 4.7%. Boston Family Office opened 7 new positions and exited 5, leaving the 255-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.

  • Boston Family Office's largest Q1 2019 buy was Enanta Pharmaceuticals: 2,750 shares worth $263K.
  • Boston Family Office added most to Air Products & Chemicals in Q1 2019, an estimated $6.4M increase.
  • Boston Family Office's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $5.4M.
  • Boston Family Office fully exited Linde in Q1 2019, selling an estimated $7.75M.
  • Boston Family Office's ten largest holdings make up 22% of its $925M portfolio in Q1 2019.
  • Boston Family Office opened 7 new positions and closed 5 in Q1 2019.
  • Boston Family Office's portfolio value rose 15% quarter-over-quarter to $925M.

Based on Boston Family Office's 13F filing for Q1 2019, filed 9 May 2019.